Beyond Penicillin: Metal Complexes as the Next Generation Antimicrobial Agents
A Chemical Approach to the Antibiotic Crisis
Keywords:
Antimicrobial resistance, Metal complexes, Metalloantibiotics, Synergistic drug design, Combinatorial chemistry, Drug discoveryAbstract
Antimicrobial resistance (AMR) represents one of the foremost global health challenges of the twenty-first century, with multi-drug-resistant pathogens increasingly undermining the efficacy of conventional antibiotics. This article critically evaluates the potential of metal complexes as alternative antimicrobial agents, drawing on their unique physicochemical properties and multifaceted mechanisms of action. Unlike traditional antibiotics, which often target a single bacterial pathway, metal complexes can simultaneously disrupt multiple cellular processes, including ligand exchange with biomolecules, generation of reactive oxygen species, membrane destabilisation, and interference with metal ion homeostasis. These broad-spectrum activities reduce the likelihood of rapid resistance development. Particular attention is given to antimony, manganese, and gallium complexes, each offering distinct therapeutic advantages: organoantimony compounds exhibit potent membrane-disrupting activity; manganese(I) tricarbonyl complexes function as carbon monoxide-releasing molecules, impairing bacterial respiration; and gallium(III) exploits iron mimicry in a “Trojan horse” strategy, effectively starving bacteria of essential nutrients. Evidence of synergistic interactions between metal complexes and established antibiotics further underscores their translational potential. Nonetheless, significant challenges persist, including host cytotoxicity, poor solubility, in vivo instability, and the environmental consequences of metal use. The article highlights the promise of combinatorial chemistry, computational screening, and synergistic drug design in overcoming these limitations. Ultimately, metal-based antimicrobials constitute a promising frontier in the fight against AMR, with the capacity to complement or supplant existing antibiotics and extend the lifespan of current therapies.
References
**World Health Organisation, WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance, World Health Organisation, Geneva, 2024. (ISBN 978-92-4-009346-1)
M. P. Ferraz, Societies, 2024, 14, 187. (DOI: 10.3390/soc14090187)
M. Lobanovska and G. Pilla, Yale J. Biol. Med., 2018, 90, 135-145. (PMID: 28356901)
** World Health Organisation, Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022, World Health Organization, Geneva, 2022. (ISBN: 9789240062702)
O. Sizar, S.W. Leslie, C.G. Unakal in StatPearls. Treasure Island (FL): StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK470553/ (Accessed January 2025).
J. Oliveira and W.C. Reygaert in StatPearls. Treasure Island (FL): StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK538213/ (Accessed January 2025).
M. Exner, S. Bhattacharya, B. Christiansen, J. Gebel, P. Goroncy-Bermes, P. Hartemann, P. Heeg, C. Ilschner, A. Kramer and E. Larson, GMS Hygiene and Infection Control, 2017, 12:Doc5. (DOI: 10.3205/dgkj000290)
**The Review on Antimicrobial Resistance chaired by J. O’Neill, https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf (Accessed November 2024).
**C. J. L. Murray, K. S. Ikuta, F. Sharara, L. Swetshinski, G. R. Aguilar, A. Gray, C. Han, C. Bisignano, P. Rao, E. Wool et al., Lancet, 2022, 399, 629-655. (DOI: 10.1016/S0140-6736(21)02724-0)
M. Naghavi, S. E. Vollset, K. S. Ikuta, L. R. Swetshinski, A. P. Gray, E. E. Wool, G. R. Aguilar, T. Mestrovic, G. Smith, C. Han et al., Lancet, 2024, 404, 1199-1226. (DOI: 10.1016/S0140-6736(24)01867-1) †
K. D. McCubbin, R. M. Anholt, E. de Jong, J. A. Ida, D. B. Nóbrega, J. P. Kastelic, J. M. Conly, M. Götte, T. A. McAllister, K. Orsel, I. Lewis, L. Jackson, G. Plastow, H.-J. Wieden, K. McCoy, M. Leslie, J. L. Robinson, L. Hardcastle, A. Hollis, N. J. Ashbolt, S. Checkley, G. J. Tyrrell, A. G. Buret, E. Rennert-May, E. Goddard, S. J. G. Otto and H. W. Barkema, Frontiers in Public Health, 2021, 9, 726484. (DOI: 10.3389/fpubh.2021.726484)
**European Environment Agency, Veterinary Antimicrobials in Europe’s Environment: A One Health Perspective, Publication Office of the European Union, 2024. (DOI: 10.2800/906575)
**R. J. Turner, BioMetals, 2024, 37, 535-559. (DOI: 10.1007/s10534-023-00565-y)
**A. Frei, J. Zuegg, A. G. Elliott, M. Baker, S. Braese, C. Brown, F. Chen, C. G. Dowson, G. Dujardin, N. Jung, A. P. King, A. M. Mansour, M. Massi, J. Moat, H. A. Mohamed, A. K. Renfrew, P. J. Rutledge, P. J. Sadler, M. H. Todd, C. E. Willans, J. J. Wilson, M. A. Cooper and M. A. T. Blaskovich, Chem. Sci., 2020, 11, 2627. (DOI: 10.1039/c9sc06460e)
T. M. Uddin, A. J. Chakraortya, A. Khusro, BM R. M. Zidan, S. Mitra, T. B. Emran, K. Dhama, Md. K. H. Ripon, M. Gajdács, M. U. K. Sahibzada, Md. J. Hossain and N. Koirala, Journal of Infection and Public Health, 2021, 14, 1750-1766. (DOI: 10.1016/j.jiph.2021.10.020)
J. J. Harrison, H. Ceri, C. A. Stremick and R. J. Turner, Environ. Microbiol., 2004, 6(12), 1220-1227. (DOI: 10.1111/j.1462-2920.2004.00656.x)
C. N. Morrison, K. E. Prosser, R. W. Stokes, A. Cordes, N. Metzler-Nolte and S. M. Cohen, Chem. Sci., 2023, 14, 10360-10362. (DOI: 10.1039/d3sc90164e)
A. J. Browne, M. G. Chipeta, G. H. Haines-Woodhouse, E. P. A. Kumaran, B. H. Kashef Hamadani, S. Zaraa, N. J. Henry, A. Deshpande, R. C. Reiner Jr, N. P. J. Day, A. D. Lopez, S. Dunachie, C. E. Moore, A. Stergachis, S. I. Hay and C. Dolecek, Lancet, 2021, 5, e893-904. (DOI: 10.1016/S254-5196(21)00280-1)
**UK Health Security Agency, English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2023 to 2024, UK Health Security Agency, UK, 2024.
M. Zhao, Y. Li and Z. Wang, Front. Pharmacol., 2022, 13, 807807. (DOI: 10.3389/fphar.2022.807807)
D. J. Barillo and D. E. Marx, Burns, 2014, 40, S3-S8. (DOI: 10.1016Pj.burns.2014.09.009)
**E. Boros, P. J. Dyson and G. Gasser, Chem., 2020, 6(1), 41-60. (DOI: 10.1016/j.chempr.2019.10.013)
**J. Karges, R. W. Stokes and S. M. Cohen, Trends Chem., 2021, 3(7), 523-534. (DOI: 10.1016/j.trechm.2021.03.006)
**A. Frei, A. D. Verderosa, A. G. Elliott, J. Zuegg and M. A. T. Blaskovich, Nat. Rev. Chem., 2023, 7, 202-224. (DOI: 10.1038/s41570-023-00463-4)
**A. Lekhan, C. Fiore, O. Shemchuk, F. Grepioni, D. Braga and R. J. Turner, ACS Appl. Bio Mater., 2022, 5, 4203-4212. (DOI: 10.1021/acsabm.2c00404)
O. Shemchuk, D. Braga, F. Grepioni and R. J. Turner, RSC Adv., 2020, 10, 2146. (DOI: 10.1039/c9ra10353h)
**J. W. Paterson, in Medical Microbiology, ed. S. Baron, University of Texas Medical Branch, Galveston (TX), 4th edition, 1996, Chapter 7. (ISBN: 0-9631172-1-1)
**M. Scaccaglia, M. P. Birbaumer, S. Pienlli, G. Pelosi and A. Frei, Chem. Sci., 2024, 15, 3907-3919. (DOI: 10.1039/D3SC05326A)
F. Ngwewa, G. Kasali, E. M. Mkupasi and A. A. S. Katakweba, J. Appl. Environ. Microbiol., 2022, 10(1), 9-16. (DOI: 10.12691/jaem-10-1-2)
**J. E. Waters, L. Stevens-Cullinane, L. Siebenmann and J. Hess, Curr. Opin. Microbiol., 2023, 75, 102347. (DOI: 10.1016/j.mic.2023.102347)
**S. Alfei, G. C. Schito, A. M. Schito and G. Zuccari, Int. J. Mol. Sci., 2024, 25, 7182. (DOI: 10.3390/ijms25137182)
F. Vatansever, W. C. M. A. de Melo, P. Avci, D. Vecchio, M. Sadasivam, A. Gupta, R. Chandran, M. Karimi, N. A. Parizotto, R. Yin, G. P. Tegos and M. R. Hamblin, FEMS Microbiol. Rev., 2013, 37(6), 955-989. (DOI: 10.1111/1574-6976.12026)
L. Holden, C. S. Burke, D. Cullinane and T. E. Keyes, RSC Chem. Biol., 2021, 2, 1021. (DOI: 10.1039/d1cb00049g)
B. Kumar, J. Devi, A. Tufail and B. Taxak, Sci. Rep., 2023, 13, 15906. (DOI: 10.1038/s41598-023-42180-4)
A. A. Mohamed, S. A. Sadeek, N. G. Rashid, H. S. Elshafie and I. Camele, Chem. Biodiversity, 2024, 21(6), e202301970. (DOI: 10.1002/cbdv.202301970)
J. A. Arnott and S. Lobo Planey, Expert Opin. Drug Discovery, 2012, 7(10), 863-875. (DOI: 10.1517/17460441.2012.714363)
J. Van der Paal, E. C. Neyts, C. C. W. Verlackt and A. Bogaerts, Chem. Sci., 2016, 7, 489. (DOI: 10.1039/c5sc02311d)
A. A. Alothman, E. S. Al-Farraj, W. A. Al-Onazi, Z. M. Almarhoon and A. M. Al-Mohaimeed, Arabian J. Chem., 2020, 13, 3998-3902. (DOI: 10.1016/j.arabjc.2019.02.003)
**S. K. Boda, S. Pandit, A. Garai, D. Pal and B. Basu, RSC Adv., 2016, 6, 39245. (DOI: 10.1039/c6ra02603f)
B. Rayner, A. D. Verderosa, V. Ferro and M. A. T. Blaskovich, RSC Med. Chem., 2023, 14, 800-822. (DOI: 10.1039/D2MD00465H)
**M. Guerrini, S. d’Agostino, F. Grepioni, D. Braga, A. Lekhan and R. J. Turner, Sci. Rep., 2022, 12, 3873. (DOI: 10.1038/s41598-022-07813-0)
K. V. Domasevitch, N. N. Gerasimchuk and A. Mokhir, Inorg. Chem., 2020, 39(6), 1227-1237. (DOI: 10.1021/ic9906048)
P. Baiocco, G. Colotti, S. FranceschiniA. Illari, J. Med. Chem., 2009, 52(8), 2603-2612. (DOI: 10.1021/jm900185q)
**T. Salpadoru, K. E. Pinks, J. A. Lieberman, K. Cotton, K. L. Wozniak, N. Gerasimchuk and M.A. Patrauchan, Microbiol. Spectrum, 2024, 12, e04234-23. (DOI: 10.1128/spectrum-04234-23)
**N. Gerasimchuk, K. Pinks, T. Salpadoru, K. Cotton, O. Michka, M.A. Patrauchan and K. L. Wozniak, Molecules, 2022, 27, 7171. (DOI: 10.3390/molecules27217171)
**S. A. Amankrah, T. Salpadoru, K. Cotton, M.A. Patrauchan, K. L. Wozniak and N. Gerasimchuk, Molecules, 2024, 29, 5779. (DOI: 10.3390/molecules29235779)
A. Frei, S. Ramu, G. J. Lowe, H. Dinh, L. Semenec, A. G. Elliott, J. Zuegg, A. Deckers, N. Jung, S. Brase, A. K. Cain and M. A. T. Blaskovich, ChemMedChem, 2021, 16, 3165-3171. (DOI: 10.1002/cmdc.202100157)
J. H. Freeland-Graves, T. Bose, A. Karbassian, in Metallotherapeutic drugs and metal-based diagnostic agents: the use of metals in medicine, ed. M. Gielen, E. R. Tiekink, John Wiley & Sons, 2005, Chapter 9, 159-178. (DOI: 10.1002/0470864052.ch9)
B. Ali and M. A. Iqbal, ChemistrySelect, 2017, 2, 1586-1604. (DOI: 10.1002/slct.201601909)
**P. V. Simpson, C. Nagel and H. Bruhn, U. Schatzchneider, Organometallics, 2015, 34, 3809-3815. (DOI: 10.1021/asc.organomet.5b00458)
**S. S. Mendes, J. Marques, E. Mesterházy, J. Straetener, M. Arts, T. Pissarro, J. Reginold, A. Berscheid, J. Bornikoel, R. M. Kluj, C. Mayer, F. Oesterhelt, S. Friaes, B. Royo, T. Schneider, H. Brotz-Oesterhelt, C. C. Romao and L. M. Saraiva, ACS Bio Med Chem Au, 2022, 2, 419-436. (DOI: 10.1021/ascbiomedchemau.2c00007)
**S. Friaes, C. Trigueiros, C. S. B. Gomes, A. R. Fernandes, O. A. Lenis-Rojas, M. Martins and B. Royo, Molecules, 2023, 28, 7453. (DOI: 10.3390/molecules28217453)
**Z. Xu, S.J. Zhao and Y. Liu, Eur. J. Med. Chem., 2019, 183, 111700. (DOI: 10.1016/j.ejmech.2019.111700)
S. Yoon, K. R. Park. S. H. Lee, S. H. Song, W. B. Park, I. J. Jang and K. S. Yu, Basic Clin. Pharmacol. Toxicol., 2017, 122(2), 233-238. (DOI: 10.1111/bcpt.12873)
R. L. Hayes, Semin. Nucl. Med., 1978, 8(3), 183-191. (DOI: 10.1016/S0001-2998(78)80027-0)
Gallium Nitrate, https://precision.fda.gov/ginas/app/ui/substances/68fb4458-4ae1-4a3f-93c5-ae9ce9faf0a7, (Accessed January 2025).
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma, https://clinicaltrials.gov/study/NCT04319276, (Accessed January 2025).
**S. R. Choi, M. A. Hassan, B. E. Britigan and P. Narayanasamy, Curr. Issues Mol. Bio., 2024, 46, 9149-9161. (DOI: 10.3390/cimb46080541)
F. Li, F. Liu, K. Huang and S. Yang, Front. Bioeng. Biotechnol., 2022, 10. (DOI: 10.3389/fbioe.2022.827960)
**S. R. Choi, B. E. Britigan and P. Narayanasamy, ACS Infect. Dis., 2019, 5, 1559, 1569. (DOI: 10.1021/ascinfecdis.9b00100)
**Z. Scott, S. R. Choi, B. E. Britigan and P. Narayanasamy, Adv. Therap, 2023, 7(7), 2400147. (DOI: 10.1002/adtp.202400147)
**C. H. Goss, Y. Kaneko, L. Khuu, G. D. Anderson, S. Ravishankar, M. L. Aitken, N. Lechtzin, G. Zhou, D. Czyz, K. McLean, O. Olakanmi, H. A. Shuman, M. Teresi, E. Wilhelm, E. Caldwell, S. J. Salipante, D. B. Hornick, R. J. Siehnel, L. Becker, B. E. Brigan and P. K. Singh, Sci. Transl. Med., 2018, 10(460), eaat7520 (DOI: 10.1126/scitranslmed.aat7520)
**Z. Scott, S. R. Choi, G. A. Talmon, B. E. Britigan and P. Narayanasamy, ACS Infect. Dis., 2022, 8, 2096-2105. (DOI: 10.1021/acsinfecdis.2c00196)
**S. R. Choi, G. A. Talmon, K. Hearne, J. Woo, V. L. Truong, B. E. Britigan and P. Narayanasamy, Mol. Pharmaceutics, 2023, 20, 4058-4070. (DOI: 10.1021/acs.molpharmaceut.3c00223)
**A. Arnold, S. McLellan and J. M. Stokes, npj Antimicrob Resist, 2025, 3, 18. (DOI: 10.1038/s44259-025-00085-4)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Elizabeth Kalusova

This work is licensed under a Creative Commons Attribution 4.0 International License.